Date: Jan 05, 2015 Source: dowjones.com (
click here to go to the source)
Lilly Ventures is leading a $15 million Series A round for Symic Holdings LLC, a startup advancing technology from Purdue University that could improve the treatment of osteoarthritis, end-stage kidney disease and other conditions.
The body's response to injury is the same regardless of what causes it. It doesn't distinguish between injuries caused by accident and those resulting from a medical procedure. As a result, scarring often occurs as a result of medical treatments, such as a surgical incision. A runaway inflammatory process also contributes to chronic conditions such as osteoarthritis, the most common form of arthritis....
